Diabetes Control in Public Assistance Recipients and Free/low-cost Medical Care Program Beneficiaries in Japan: a Retrospective Cross-sectional Study

Overview

Journal BMJ Public Health

Publisher BMJ Publishing Group

Date 2025 Feb 28

PMID 40018237

Authors

Mitsuhiko Funakoshi

Daisuke Nishioka

Seiji Haruguchi

Sakae Yonemura

Takashi Takebe

Misato Nonaka

Sanae Iwashita

Affiliations

Soon will be listed here.

Abstract

Introduction: Previous research has highlighted the association between socioeconomic factors and diabetes management. This study aimed to elucidate the blood glucose control status among individuals with low income (ie, recipients of public assistance (PARs) and free/low-cost medical care (FLCMC) programme beneficiaries) and to investigate the effects of public subsidies for medical expenses on treatment adherence among low-income patients with diabetes.

Methods: We conducted a secondary analysis of medical records from 910 outpatients with diabetes who underwent pharmacological treatment for >90 days. Data on predictive variables, such as glycated haemoglobin (HbA1c) level and control variables, including sex, age and insurance type, were obtained retrospectively. The HbA1c levels among public health insurance (PHI)-only beneficiaries, FLCMC programme beneficiaries and PARs were compared using logistic regression analysis.

Results: The analysis included 874 individuals, among whom the majority were men (61.7%) and aged≥65 years (58.4%). Logistic regression analysis revealed that among individuals aged ˂65 years, the adjusted ORs for HbA1c levels above 9% were significantly higher in FLCMC programme beneficiaries (OR=5.37, 95% CI: 2.23 to 12.82) and PARs (OR=5.97, 95% CI: 2.91 to 12.74) than in PHI-only beneficiaries. Among patients aged ˂65 years with HbA1c levels above 7%, the adjusted OR was significantly higher in FLCMC programme beneficiaries (OR=3.82, 95% CI: 1.65 to 10.43) than in PHI-only beneficiaries. Additionally, the adjusted OR was significantly higher in FLCMC programme beneficiaries aged ˂65 years (OR=2.57, 95% CI: 1.02 to 7.44) than in PARs.

Conclusions: This study highlights the predictive value of public assistance or the FLCMC programme for poor blood glucose control and suggests the inadequacy of current medical expense subsidies to eliminate health disparities in diabetes control.

References

Celeste R, Fritzell J . Do socioeconomic inequalities in pain, psychological distress and oral health increase or decrease over the life course? Evidence from Sweden over 43 years of follow-up. J Epidemiol Community Health. 2017; 72(2):160-167. PMC: 5800356. DOI: 10.1136/jech-2017-209123. View

Moscrop A, Ziebland S, Roberts N, Papanikitas A . A systematic review of reasons for and against asking patients about their socioeconomic contexts. Int J Equity Health. 2019; 18(1):112. PMC: 6652018. DOI: 10.1186/s12939-019-1014-2. View

Scott A, Chambers D, Goyder E, OCathain A . Socioeconomic inequalities in mortality, morbidity and diabetes management for adults with type 1 diabetes: A systematic review. PLoS One. 2017; 12(5):e0177210. PMC: 5425027. DOI: 10.1371/journal.pone.0177210. View

Ngo-Metzger Q, Sorkin D, Billimek J, Greenfield S, Kaplan S . The effects of financial pressures on adherence and glucose control among racial/ethnically diverse patients with diabetes. J Gen Intern Med. 2011; 27(4):432-7. PMC: 3304038. DOI: 10.1007/s11606-011-1910-7. View

Branfield Day L, Austin P, Shah B . Universal drug coverage and income-related disparities in glycaemic control. Diabet Med. 2019; 37(5):822-827. DOI: 10.1111/dme.14051. View

Gary-Webb T, Suglia S, Tehranifar P . Social epidemiology of diabetes and associated conditions. Curr Diab Rep. 2013; 13(6):850-9. PMC: 3908819. DOI: 10.1007/s11892-013-0427-3. View

Piette J, Heisler M, Wagner T . Problems paying out-of-pocket medication costs among older adults with diabetes. Diabetes Care. 2004; 27(2):384-91. DOI: 10.2337/diacare.27.2.384. View

Lantz P, House J, Lepkowski J, Williams D, Mero R, Chen J . Socioeconomic factors, health behaviors, and mortality: results from a nationally representative prospective study of US adults. JAMA. 1998; 279(21):1703-8. DOI: 10.1001/jama.279.21.1703. View

Nagamine Y, Kondo N, Yokobayashi K, Ota A, Miyaguni Y, Sasaki Y . Socioeconomic Disparity in the Prevalence of Objectively Evaluated Diabetes Among Older Japanese Adults: JAGES Cross-Sectional Data in 2010. J Epidemiol. 2018; 29(8):295-301. PMC: 6614078. DOI: 10.2188/jea.JE20170206. View

10.

Funakoshi M, Azami Y, Matsumoto H, Ikota A, Ito K, Okimoto H . Socioeconomic status and type 2 diabetes complications among young adult patients in Japan. PLoS One. 2017; 12(4):e0176087. PMC: 5402943. DOI: 10.1371/journal.pone.0176087. View

11.

Caraballo C, Valero-Elizondo J, Khera R, Mahajan S, Grandhi G, Virani S . Burden and Consequences of Financial Hardship From Medical Bills Among Nonelderly Adults With Diabetes Mellitus in the United States. Circ Cardiovasc Qual Outcomes. 2020; 13(2):e006139. DOI: 10.1161/CIRCOUTCOMES.119.006139. View

12.

Hill-Briggs F, Adler N, Berkowitz S, Chin M, Gary-Webb T, Navas-Acien A . Social Determinants of Health and Diabetes: A Scientific Review. Diabetes Care. 2020; . PMC: 7783927. DOI: 10.2337/dci20-0053. View

13.

Stratton I, Adler A, Neil H, Matthews D, Manley S, Cull C . Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000; 321(7258):405-12. PMC: 27454. DOI: 10.1136/bmj.321.7258.405. View

14.

Shahidi F, Ramraj C, Sod-Erdene O, Hildebrand V, Siddiqi A . The impact of social assistance programs on population health: a systematic review of research in high-income countries. BMC Public Health. 2019; 19(1):2. PMC: 6318923. DOI: 10.1186/s12889-018-6337-1. View

15.

Studer C, Linder M, Pazzagli L . A global systematic overview of socioeconomic factors associated with antidiabetic medication adherence in individuals with type 2 diabetes. J Health Popul Nutr. 2023; 42(1):122. PMC: 10631092. DOI: 10.1186/s41043-023-00459-2. View

16.

Nishioka D, Saito J, Ueno K, Kondo N . Non-financial social determinants of diabetes among public assistance recipients in Japan: A cohort study. J Diabetes Investig. 2020; 12(6):1104-1111. PMC: 8169356. DOI: 10.1111/jdi.13435. View

17.

Park J, Zhang P, Wang Y, Zhou X, Look K, Bigman E . High Out-of-pocket Health Care Cost Burden Among Medicare Beneficiaries With Diabetes, 1999-2017. Diabetes Care. 2021; 44(8):1797-1804. PMC: 8376067. DOI: 10.2337/dc20-2708. View

18.

Sengoku T, Ishizaki T, Goto Y, Iwao T, Ohtera S, Sakai M . Prevalence of type 2 diabetes by age, sex and geographical area among two million public assistance recipients in Japan: a cross-sectional study using a nationally representative claims database. J Epidemiol Community Health. 2021; 76(4):391-397. DOI: 10.1136/jech-2020-216158. View

19.

Bijlsma-Rutte A, Rutters F, Elders P, Bot S, Nijpels G . Socio-economic status and HbA in type 2 diabetes: A systematic review and meta-analysis. Diabetes Metab Res Rev. 2018; 34(6):e3008. DOI: 10.1002/dmrr.3008. View